{"title":"Anti-TNF-alpha drugs - moving into the mainstream?","authors":"Tina Ding MSc, MRCP, Chris Deighton BMedSci, MD, FRCP","doi":"10.1002/fps.55","DOIUrl":null,"url":null,"abstract":"<p>Anti-TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease-modifying antirheumatic drugs (DMARDs). Drs Chris Deighton and Tina Ding review the available anti-TNF-alpha drugs, and consider their future place in therapy. Copyright © 2009 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"10 4","pages":"6-8"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.55","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.55","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Anti-TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease-modifying antirheumatic drugs (DMARDs). Drs Chris Deighton and Tina Ding review the available anti-TNF-alpha drugs, and consider their future place in therapy. Copyright © 2009 John Wiley & Sons, Ltd.
抗tnf - α药物——进入主流?
抗肿瘤坏死因子药物是治疗炎症性疾病(如类风湿关节炎)的主要治疗进展，通常在使用常规疾病改善抗风湿药物(DMARDs)治疗失败后被考虑。克里斯·戴顿博士和蒂娜·丁博士回顾了现有的抗tnf - α药物，并考虑了它们在治疗中的未来地位。版权所有©2009 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
